IGF2 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia cells IGF2BP3 depletion determined a reduction of IGF2 production and increased susceptibility to ionizing radiation as measured by apoptosis, effect that was partially reversed by treatment with recombinant IGF2 [128].